DOP2004000893A - PDE9 INHIBITORS TO TREAT TYPE 2 DIABETES, METABOLIC SYNDROME AND CARDIOVASCULAR DISEASES - Google Patents

PDE9 INHIBITORS TO TREAT TYPE 2 DIABETES, METABOLIC SYNDROME AND CARDIOVASCULAR DISEASES

Info

Publication number
DOP2004000893A
DOP2004000893A DO2004000893A DO2004000893A DOP2004000893A DO P2004000893 A DOP2004000893 A DO P2004000893A DO 2004000893 A DO2004000893 A DO 2004000893A DO 2004000893 A DO2004000893 A DO 2004000893A DO P2004000893 A DOP2004000893 A DO P2004000893A
Authority
DO
Dominican Republic
Prior art keywords
diabetes
metabolic syndrome
cardiovascular diseases
treat type
pde9 inhibitors
Prior art date
Application number
DO2004000893A
Other languages
Spanish (es)
Inventor
Andrew Simon Bell
Michael John Palmer
Michael Paul Deninno
Michael Scott Visser
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to DO2004000893A priority Critical patent/DOP2004000893A/en
Publication of DOP2004000893A publication Critical patent/DOP2004000893A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invencion proporciona los compuestos de formula (I) los estereoisomeros y los profarmacos de los mismos, y las sales de los compuestos, estereoisomeros, y profarmacos farmaceuticamente aceptables, en la que A, P, J, x y R10 son como se han definido en esta memoria descriptiva; las composiciones farmaceuticas de los mismos; y los procedimientos de use de las composiciones farmaceuticas para el tratamiento de enfermedades, incluyendo diabetes, que incluye diabetes tipo 1 y tipo 2, hiperglucemia, dislipidemia, tolerancia a la glucosa alterada, sindrome metabolico, y/o enfermedad cardiovascular.The invention provides the compounds of formula (I) the stereoisomers and the prodrugs thereof, and the salts of the pharmaceutically acceptable compounds, stereoisomers, and prodrugs, wherein A, P, J, x and R10 are as defined in this descriptive report; the pharmaceutical compositions thereof; and the methods of using the pharmaceutical compositions for the treatment of diseases, including diabetes, which includes type 1 and type 2 diabetes, hyperglycemia, dyslipidemia, impaired glucose tolerance, metabolic syndrome, and / or cardiovascular disease.

DO2004000893A 2004-04-29 2004-04-29 PDE9 INHIBITORS TO TREAT TYPE 2 DIABETES, METABOLIC SYNDROME AND CARDIOVASCULAR DISEASES DOP2004000893A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2004000893A DOP2004000893A (en) 2004-04-29 2004-04-29 PDE9 INHIBITORS TO TREAT TYPE 2 DIABETES, METABOLIC SYNDROME AND CARDIOVASCULAR DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2004000893A DOP2004000893A (en) 2004-04-29 2004-04-29 PDE9 INHIBITORS TO TREAT TYPE 2 DIABETES, METABOLIC SYNDROME AND CARDIOVASCULAR DISEASES

Publications (1)

Publication Number Publication Date
DOP2004000893A true DOP2004000893A (en) 2004-11-30

Family

ID=44261350

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2004000893A DOP2004000893A (en) 2004-04-29 2004-04-29 PDE9 INHIBITORS TO TREAT TYPE 2 DIABETES, METABOLIC SYNDROME AND CARDIOVASCULAR DISEASES

Country Status (1)

Country Link
DO (1) DOP2004000893A (en)

Similar Documents

Publication Publication Date Title
HN2008001666A (en) ACID DERIVATIVES OF CICLOALQUILAMINO
PA8622401A1 (en) ACID DERIVATIVES 7-PHENYLAMINE-4-QUINOLONA-3-CARBOXILICO, PROCESSES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS
GT200800148A (en) THERAPEUTIC AGENT FOR INTESTINAL INFLAMMATORY DISEASE CONTAINING AS AN ACTIVE INGREDIENT A 2-AMINO-1,3-PROPANEDIOL DERIVATIVE OR A METHOD FOR THE TREATMENT OF INTESTINAL INFLAMMATORY DISEASE.
CR8147A (en) PIRIDO DERIVATIVES 2, 1A-ISOQUINOLINE, AS DPP-IV INHIBITORS
ECSP088747A (en) PIRAZOLES AS INHIBITORS OF THE 11-BETA-HSD1
ECSP088869A (en) DERIVATIVES OF 2-PIRAZINONE FOR THE TREATMENT OF DISEASES OR CONDITIONS WHERE THE INHIBITION OF THE ACTIVITY OF NEUTROPHYLICAL ELASTASA IS BENEFICIAL
ECSP067054A (en) NEW FLUOROGLYCOSIDIC DERIVATIVES OF PIRAZOLES, MEDICINES CONTAINING THESE COMPOUNDS, AND THE USE OF THEMSELVES
DOP2010000013A (en) DERIVATIVES OF PIRIMIDINE TRISUSTITUIDA FOR THE TREATMENT OF PROLIFERATIVE DISEASES
PA8623001A1 (en) SUBSTITUTED QUINOLINE COMPOUNDS
DOP2010000103A (en) PIRROLO DERIVATIVES [2,3-D] PYRIMIDINE AS INHIBITORS OF KINASE PROTEINS B
UY30500A1 (en) AZABENCIMIDAZOLILO COMPOUNDS
ECSP088099A (en) NEW DERIVATIVES OF 2-AZETIDINONE FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES
PA8587101A1 (en) NEW DERIVATIVES OF DIHYDROPIRIMIDO [4,5-D] PIRIMIDINONE REPLACED BY AMIINO, MANUFACTURE AND USE OF THE SAME AS PHARMACEUTICAL AGENTS
UY28923A1 (en) THERAPEUTIC COMPOUNDS: PYRIDINE AS A BASE STRUCTURE
PA8748101A1 (en) BENZOXAZOLES AND OXAZOLOPIRIDINS THAT ARE USEFUL AS INHIBITORS OF JANUS KINASES
ECSP088511A (en) NEUROPEPTIDO-2 RECEIVER AGONISTS
CR9954A (en) PIRAZINE DERIVATIVES
UY30460A1 (en) THERAPEUTIC COMPOUNDS
CR9667A (en) BENZAMIDA DERIVATIVES AND USES RELATED TO THE SAME
CR10489A (en) PHENYL-PIRAZOL DERIVATIVES AS LEGANDS OF NON-STEROID GLUCOCORTICOID RECEPTORS
UY30377A1 (en) FUSIONATED TRICYCLE INHIBITORS OF SULFONAMIDE OF GAMA-SECRETASA
PA8621901A1 (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
UY28922A1 (en) RECEIVER CB1 LINKS USEFUL IN THE TREATMENT OF PAIN AND / OR OTHER SYMPTOMS OR RELATED DISEASES; PHARMACEUTICAL COMPOUNDS AND THEIR PREPARATION.
UY31322A1 (en) HETEROCYCLIC AMIDAS AND ITS METHODS OF USE-975
HN2003000379A (en) USEFUL ANILINOPIRAZOL DERIVATIVES IN THE TREATMENT OF DIABETES